ATC groups

Anatomicko-terapeuticko-chemické skupiny jsou definovány Světovou zdravotnickou organizací, viz www.whocc.no.

± A: ALIMENTARY TRACT AND METABOLISM

± B: BLOOD AND BLOOD FORMING ORGANS

± C: CARDIOVASCULAR SYSTEM

± D: DERMATOLOGICALS

± G: GENITO URINARY SYSTEM AND SEX HORMONES

± H: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

± J: ANTIINFECTIVES FOR SYSTEMIC USE

± L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

± L01: ANTINEOPLASTIC AGENTS

± L02: ENDOCRINE THERAPY

± L03: IMMUNOSTIMULANTS

± L04: IMMUNOSUPPRESSANTS

± L04A: IMMUNOSUPPRESSANTS

± L04AA: SELECTIVE IMMUNOSUPPRESSANTS

± L04AB: TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS

± L04AC: INTERLEUKIN INHIBITORS

L04AC01: DACLIZUMAB

L04AC02: BASILIXIMAB

L04AC03: ANAKINRA

L04AC04: RILONACEPT

L04AC05: USTEKINUMAB

L04AC07: TOCILIZUMAB

L04AC08: CANAKINUMAB

L04AC09: BRIAKINUMAB

L04AC10: SECUKINUMAB

L04AC11: SILTUXIMAB

L04AC12: BRODALUMAB

L04AC13: IXEKIZUMAB

L04AC14: SARILUMAB

L04AC15: SIRUKUMAB

L04AC16: GUSELKUMAB

L04AC17: TILDRAKIZUMAB

L04AC18: RISANKIZUMAB

L04AC19: SATRALIZUMAB

L04AC20: NETAKIMAB

L04AC21: BIMEKIZUMAB

L04AC22: SPESOLIMAB

± L04AD: CALCINEURIN INHIBITORS

± L04AX: OTHER IMMUNOSUPPRESSANTS

± M: MUSCULO-SKELETAL SYSTEM

± N: NERVOUS SYSTEM

± P: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

± R: RESPIRATORY SYSTEM

± S: SENSORY ORGANS

± V: VARIOUS